Shareholder Alert: Ademi LLP investigates whether SOC Telemed, Inc. has obtained a Fair Price in its transaction with Patient Square.
MILWAUKEE, Feb. 3, 2022 /PRNewswire/ -- Ademi LLP is investigating SOC Telemed (NASDAQ: TLMD) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square.
Click here to learn how to join the action: https://www.ademilaw.com/case/soc-telemed-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges SOC Telemed's financial outlook and prospects are excellent and yet SOC Telemed shareholders will receive only $3 per share. The merger agreement unreasonably limits competing bids for SOC Telemed by prohibiting solicitation of further bids, and imposing a significant penalty if SOC Telemed accepts a superior bid. SOC Telemed insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of SOC Telemed's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for SOC Telemed.
If you own SOC Telemed common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/soc-telemed-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article